East Coast Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-404
| Closed | -$201K | – | 73 |
|
2025
Q1 | $201K | Buy |
+404
| New | +$201K | 0.07% | 69 |
|
2024
Q4 | – | Sell |
-380
| Closed | -$235K | – | 73 |
|
2024
Q3 | $235K | Hold |
380
| – | – | 0.08% | 69 |
|
2024
Q2 | $210K | Hold |
380
| – | – | 0.08% | 69 |
|
2024
Q1 | $221K | Hold |
380
| – | – | 0.08% | 66 |
|
2023
Q4 | $202K | Buy |
+380
| New | +$202K | 0.08% | 64 |
|
2023
Q2 | – | Sell |
-380
| Closed | -$219K | – | 64 |
|
2023
Q1 | $219K | Sell |
380
-45
| -11% | -$25.9K | 0.1% | 61 |
|
2022
Q4 | $234K | Hold |
425
| – | – | 0.12% | 58 |
|
2022
Q3 | $216K | Hold |
425
| – | – | 0.12% | 56 |
|
2022
Q2 | $231K | Hold |
425
| – | – | 0.11% | 57 |
|
2022
Q1 | $251K | Hold |
425
| – | – | 0.06% | 59 |
|
2021
Q4 | $284K | Hold |
425
| – | – | 0.06% | 59 |
|
2021
Q3 | $243K | Hold |
425
| – | – | 0.06% | 60 |
|
2021
Q2 | $214K | Buy |
+425
| New | +$214K | 0.05% | 63 |
|
2013
Q3 | – | Sell |
-691
| Closed | -$58K | – | 303 |
|
2013
Q2 | $58K | Buy |
+691
| New | +$58K | 0.03% | 215 |
|